1. Blau N (2006) Nomenclature and laboratory diagnosis of tetrahydrobiopterin deficiencies. In: Blau N, ed. PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin. Heilbronn: SPS Verlagsgesellschaft, 555–567.
2. Blau N, Burgard P (2005) Disorders of phenylalanine and tetrahydrobiopterin. In: Blau N, Hoffmann G, Leonard J, Clarke J, eds. Physician’s Guide to the Treatment and Follow-up of Metabolic Diseases. Berlin, Heidelberg, New York: Springer, 25–34.
3. Blau N, Bonafe L, Blascovics ME (2003) Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N, Duran M, Blascovics ME, Gibson KM, eds. Physician’s Guide to the Laboratory Diagnosis of Metabolic Diseases. Berlin, Heidelberg, New York: Springer, 89–106.
4. Brunelli S, Faiella A, Capra V, et al (1996) Germline mutation in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet 12: 94–96. doi: 10.1038/ng0196-94 .
5. Dhondt J-L (2006) Follow-up and outcome of tetrahydrobiopterin deficiencies. In: Blau N, ed. PKU and BH4: Advances in Phenylketonuria and Tetrahydrobiopterin. Heilbronn: SPS Verlagsgesellschaft, 652–677.